<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; VAR</title>
	<atom:link href="http://www.stockbloghub.com/tag/var/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Thu, 24 May 2012 23:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(MDT) MedTech Industry Stock Outlook &#8211; March 2012 &#8211; Zacks Analyst Interviews</title>
		<link>http://www.stockbloghub.com/2012/03/19/mdt-medtech-industry-stock-outlook-march-2012-zacks-analyst-interviews/94611</link>
		<comments>http://www.stockbloghub.com/2012/03/19/mdt-medtech-industry-stock-outlook-march-2012-zacks-analyst-interviews/94611#comments</comments>
		<pubDate>Tue, 20 Mar 2012 02:13:00 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94611</guid>
		<description><![CDATA[Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure volume pressures. The difficult macroeconomic backdrop, pricing headwinds, austerity measures, reimbursement pressure, a still unstable job market and the impact of health care reform continue to weigh on the medical devices industry, exacerbated by Europe&#8217;s sovereign debt plight. With fewer patients going under the knife accompanied by concerns of overuse of devices, companies in the cardiovascular and orthopedic domain continue to grapple with tepid utilization. After having a buoyant first half, the MedTech sector went through a rough patch in the back half of 2011 given the weakened sector fundamentals, sluggish key end-markets ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/19/mdt-medtech-industry-stock-outlook-march-2012-zacks-analyst-interviews/94611/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) MedTech Industry Stock Outlook &#8211; March 2012 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2012/03/08/mdt-medtech-industry-stock-outlook-march-2012-industry-outlook/94609</link>
		<comments>http://www.stockbloghub.com/2012/03/08/mdt-medtech-industry-stock-outlook-march-2012-industry-outlook/94609#comments</comments>
		<pubDate>Thu, 08 Mar 2012 19:28:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94609</guid>
		<description><![CDATA[Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure volume pressures. The difficult macroeconomic backdrop, pricing headwinds, austerity measures, reimbursement pressure, a still unstable job market and the impact of health care reform continue to weigh on the medical devices industry, exacerbated by Europe&#8217;s sovereign debt plight. With fewer patients going under the knife accompanied by concerns of overuse of devices, companies in the cardiovascular and orthopedic domain continue to grapple with tepid utilization. After having a buoyant first half, the MedTech sector went through a rough patch in the back half of 2011 given the weakened sector fundamentals, sluggish key end-markets ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/08/mdt-medtech-industry-stock-outlook-march-2012-industry-outlook/94609/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ATHN) Grading the Investment U Gurus 2011: Marc Lichtenfeld</title>
		<link>http://www.stockbloghub.com/2012/01/09/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld-2/89047</link>
		<comments>http://www.stockbloghub.com/2012/01/09/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld-2/89047#comments</comments>
		<pubDate>Mon, 09 Jan 2012 16:44:49 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Business Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[AINV]]></category>
		<category><![CDATA[Allegheny Technologies Inc]]></category>
		<category><![CDATA[Apollo Investment Corporation]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[ATI]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[Capstead Mortgage Corporation]]></category>
		<category><![CDATA[CMO]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FAST]]></category>
		<category><![CDATA[Fastenal Company]]></category>
		<category><![CDATA[Genuine Parts Company]]></category>
		<category><![CDATA[GPC]]></category>
		<category><![CDATA[ISIS]]></category>
		<category><![CDATA[Isis Pharmaceuticals Inc]]></category>
		<category><![CDATA[JOE]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>
		<category><![CDATA[MDP]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[Meredith Corporation]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[NOC]]></category>
		<category><![CDATA[Northrop Grumman Corporation]]></category>
		<category><![CDATA[Old Republic International Corporation]]></category>
		<category><![CDATA[ORI]]></category>
		<category><![CDATA[The St. Joe Company]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VF Corporation]]></category>
		<category><![CDATA[VFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89047</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U Senior Analyst Tuesday, December 20, 2011: Issue #1668 I’m excited when my kids bring home their report cards. They’re terrific students, work hard and always bring home good grades. However, it’s always a little nerve-wracking to tabulate my own report card based on my market calls at the end of the year. The market isn’t nearly as forgiving as a second grade teacher. But nevertheless, it’s an important exercise to see what I got right and what I got wrong… what I may have been a little “early” on. So here goes: In my January 14 column, I talked about the rising trend of healthcare information technology and said two of my favorite stocks in the space were AthenaHealth (Nasdaq: ATHN) and McKesson (NYSE: MCK). ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/09/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld-2/89047/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ATHN) Grading the Investment U Gurus 2011: Marc Lichtenfeld</title>
		<link>http://www.stockbloghub.com/2011/12/21/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld/88979</link>
		<comments>http://www.stockbloghub.com/2011/12/21/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld/88979#comments</comments>
		<pubDate>Wed, 21 Dec 2011 17:42:14 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Business Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[AINV]]></category>
		<category><![CDATA[Allegheny Technologies Inc]]></category>
		<category><![CDATA[Apollo Investment Corporation]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[Athenahealth Inc]]></category>
		<category><![CDATA[ATHN]]></category>
		<category><![CDATA[ATI]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[Capstead Mortgage Corporation]]></category>
		<category><![CDATA[CMO]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FAST]]></category>
		<category><![CDATA[Fastenal Company]]></category>
		<category><![CDATA[Genuine Parts Company]]></category>
		<category><![CDATA[GPC]]></category>
		<category><![CDATA[ISIS]]></category>
		<category><![CDATA[Isis Pharmaceuticals Inc]]></category>
		<category><![CDATA[JOE]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>
		<category><![CDATA[MDP]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[Meredith Corporation]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[NOC]]></category>
		<category><![CDATA[Northrop Grumman Corporation]]></category>
		<category><![CDATA[Old Republic International Corporation]]></category>
		<category><![CDATA[ORI]]></category>
		<category><![CDATA[The St. Joe Company]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VF Corporation]]></category>
		<category><![CDATA[VFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=88979</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U Senior Analyst Tuesday, December 20, 2011: Issue #1668 I’m excited when my kids bring home their report cards. They’re terrific students, work hard and always bring home good grades. However, it’s always a little nerve-wracking to tabulate my own report card based on my market calls at the end of the year. The market isn’t nearly as forgiving as a second grade teacher. But nevertheless, it’s an important exercise to see what I got right and what I got wrong… what I may have been a little “early” on. So here goes: In my January 14 column, I talked about the rising trend of healthcare information technology and said two of my favorite stocks in the space were AthenaHealth (Nasdaq: ATHN) and McKesson (NYSE: MCK). ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/21/athn-grading-the-investment-u-gurus-2011-marc-lichtenfeld/88979/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Technology Industry Stock Outlook &#8211; November 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/11/18/mdt-medical-technology-industry-stock-outlook-november-2011-industry-outlook/87069</link>
		<comments>http://www.stockbloghub.com/2011/11/18/mdt-medical-technology-industry-stock-outlook-november-2011-industry-outlook/87069#comments</comments>
		<pubDate>Fri, 18 Nov 2011 18:52:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[THOR]]></category>
		<category><![CDATA[Thoratec Corporation]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=87069</guid>
		<description><![CDATA[The performance of incumbent players in the MedTech industry continued to be hamstrung by a spate of macro issues (including sustained price and procedure volume pressures) in the September quarter. The prevailing macroeconomic factors, pricing headwinds, austerity measures, reimbursement pressure and the impact of health care reform continues to weigh on the medical devices industry, exacerbated by Europe&#8217;s sovereign debt plight. The beleaguered U.S. implantable defibrillator market continues to bother cardiac devices makers, as reflected by sustained implant volume pressure. On the other hand, companies in the orthopedic domain remain affected by a still choppy reconstructive implant market as they faced sustained pressure across hip, knee and spine businesses in the third quarter (albeit to a lesser extent vis-à-vis the sequentially prior quarter). Although a number of these issues are ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/18/mdt-medical-technology-industry-stock-outlook-november-2011-industry-outlook/87069/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Stock Outlook &#8211; Sept. 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/09/08/mdt-medical-devices-stock-outlook-sept-2011-industry-outlook/82743</link>
		<comments>http://www.stockbloghub.com/2011/09/08/mdt-medical-devices-stock-outlook-sept-2011-industry-outlook/82743#comments</comments>
		<pubDate>Thu, 08 Sep 2011 19:53:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82743</guid>
		<description><![CDATA[June quarter results mostly mirror the preceding quarter as a host of macro headwinds (including price and procedure volume pressures) continued to haunt the MedTech industry and weighed on the performance of the incumbent players. Although a number of these issues are expected to linger over the second-half of 2011, the industry is expected to fare relatively better this year thanks to several tailwinds and growth opportunities. Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative, with estimated worldwide sales of more than $300 billion in 2011. The U.S. is the largest market, with estimated sales of roughly $95 billion in 2010. The highly-regulated medical devices industry is divided into different segments including Cardiology, Oncology, Neuro, Orthopedic and Aesthetic Devices. The U.S. medical devices ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/08/mdt-medical-devices-stock-outlook-sept-2011-industry-outlook/82743/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ARAY) Accuray Presents Promising CyberKnife Radiosurgery Data</title>
		<link>http://www.stockbloghub.com/2011/07/11/aray-accuray-presents-promising-cyberknife-radiosurgery-data/78691</link>
		<comments>http://www.stockbloghub.com/2011/07/11/aray-accuray-presents-promising-cyberknife-radiosurgery-data/78691#comments</comments>
		<pubDate>Mon, 11 Jul 2011 15:44:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Accuray Incorporated]]></category>
		<category><![CDATA[ARAY]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78691</guid>
		<description><![CDATA[Leading radiosurgery systems maker Accuray Incorporated (ARAY) has presented encouraging new clinical data highlighting the benefits of its popular CyberKnife radiosurgery system and its recently acquired TomoTherapy radiation therapy system in treating a vast continuum of lung cancer patients. The data was presented at the World Conference on Lung Cancer (“WCLC”), which took place in Amsterdam, The Netherlands, between July 3 and 7, 2011. WCLC, hosted by the International Association for the Study of Lung Cancer (“IASLC”), is the leading international forum for lung cancer and thoracic oncology research and practice. IASLC is the only global organization dedicated to the study of lung cancer. The CyberKnife system delivers ablative doses of radiation to lung tumors with the highest levels of accuracy. Moreover, the TomoTherapy system delivers high quality intensity modulated ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/11/aray-accuray-presents-promising-cyberknife-radiosurgery-data/78691/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(VAR) Varian Medical TrueBeam Lands in Sweden</title>
		<link>http://www.stockbloghub.com/2011/07/06/var-varian-medical-truebeam-lands-in-sweden/78480</link>
		<comments>http://www.stockbloghub.com/2011/07/06/var-varian-medical-truebeam-lands-in-sweden/78480#comments</comments>
		<pubDate>Wed, 06 Jul 2011 19:26:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Accuray Incorporated]]></category>
		<category><![CDATA[ARAY]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78480</guid>
		<description><![CDATA[Leading integrated radiotherapy systems maker Varian Medical’s (VAR) coveted TrueBeam radiotherapy and radiosurgery system has made its Scandinavian debut as it was successfully placed at a leading hospital in Sweden. The advanced therapy system has begun treating cancer patients at Vasteras Hospital in Stockholm, the only hospital offering radiotherapy in Sweden. Doctors at Vasteras Hospital used the TrueBeam system to treat a 71-year old prostate cancer patient who became the first patient in Sweden to receive treatment with this novel therapy system. Prior to the arrival of the TrueBeam system, physicians at Vasteras Hospital have been treating 70 patients per day in two shifts. TrueBeam has enabled rapid treatment delivery while potentially allowing resumption of normal working patterns. Varian’s TrueBeam platform, launched in April 2010, is used in image-guided radiotherapy ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/06/var-varian-medical-truebeam-lands-in-sweden/78480/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(VAR) Varian Medical TrueBeam Makes China Debut</title>
		<link>http://www.stockbloghub.com/2011/07/01/var-varian-medical-truebeam-makes-china-debut/78224</link>
		<comments>http://www.stockbloghub.com/2011/07/01/var-varian-medical-truebeam-makes-china-debut/78224#comments</comments>
		<pubDate>Fri, 01 Jul 2011 20:31:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Accuray Incorporated]]></category>
		<category><![CDATA[ARAY]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78224</guid>
		<description><![CDATA[Leading integrated radiotherapy systems maker Varian Medical (VAR) has achieved another key milestone as its popular TrueBeam therapy system has been successfully deployed at Shantou University Medical College&#8217;s affiliated cancer hospital, thereby becoming the first cancer treatment center in China to install this advanced system. Shantou University Medical College is a premier medical college and health research base in southern-eastern China. The TrueBeam system was donated to the hospital by private charitable organization Li Ka Shing (“LKS”) Foundation. It was dedicated in a special ceremony held at the affiliated hospital on June 28. TrueBeam was approved in China in early 2011. Varian recently secured the Japanese regulator&#8217;s clearance for the system. Introduced in April 2010, the TrueBeam platform is used in image-guided radiotherapy and radiosurgery to treat multiple cancer types. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/01/var-varian-medical-truebeam-makes-china-debut/78224/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(VAR) Varian Medical Systems Wins R&amp;D 100 Award</title>
		<link>http://www.stockbloghub.com/2011/06/26/var-varian-medical-systems-wins-rd-100-award/77411</link>
		<comments>http://www.stockbloghub.com/2011/06/26/var-varian-medical-systems-wins-rd-100-award/77411#comments</comments>
		<pubDate>Sun, 26 Jun 2011 17:43:13 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Accuray Incorporated]]></category>
		<category><![CDATA[ARAY]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77411</guid>
		<description><![CDATA[Leading integrated radiotherapy systems maker Varian Medical Systems (VAR) recently disclosed that its image guided radiotherapy and radiosurgery system (TrueBeam) is the recipient of a 2011 R&#38;D 100 Award conferred by R&#38;D Magazine. This yearly felicitation recognizes 100 technologically superior products from the previous year. R&#38;D Awards, established by the editors of R&#38;D Magazine, are given on an annual basis. This award is widely recognized as a hallmark of excellence and indicates that the product incorporates some of the most innovative thinking of the year. The TrueBeam system integrates a series of technological innovations so as to coordinate imaging, delivery of treatment, the position of the patient and his/her motion. TrueBeam also has the capability to achieve a dose delivery rate that is about twice the full output of orthodox ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/26/var-varian-medical-systems-wins-rd-100-award/77411/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Stock Outlook &#8211; June 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/06/22/mdt-medical-devices-stock-outlook-june-2011-industry-outlook/77179</link>
		<comments>http://www.stockbloghub.com/2011/06/22/mdt-medical-devices-stock-outlook-june-2011-industry-outlook/77179#comments</comments>
		<pubDate>Thu, 23 Jun 2011 01:09:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[S]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[Sprint Nextel Corporation]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77179</guid>
		<description><![CDATA[A host of macro headwinds (including price and procedure volume pressure) which hit the MedTech industry last year continued to haunt the sector during the March quarter and encumber growth. Although a number of these issues are expected to linger through the remainder of 2011, the industry is expected to fare relatively better this year thanks to several tailwinds and growth opportunities. Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative, with estimated worldwide sales of more than $300 billion in 2011. The U.S. is the largest market, with estimated sales of roughly $95 billion in 2010. The medical devices industry is divided into different segments including Cardiology, Oncology, Neuro, Orthopedic and Aesthetic Devices. The U.S. medical devices industry continues to grow at a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/22/mdt-medical-devices-stock-outlook-june-2011-industry-outlook/77179/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(VAR) Varian Medical Systems Wins Shonin in Japan</title>
		<link>http://www.stockbloghub.com/2011/06/20/var-varian-medical-systems-wins-shonin-in-japan/76601</link>
		<comments>http://www.stockbloghub.com/2011/06/20/var-varian-medical-systems-wins-shonin-in-japan/76601#comments</comments>
		<pubDate>Mon, 20 Jun 2011 19:47:59 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Accuray Incorporated]]></category>
		<category><![CDATA[ARAY]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=76601</guid>
		<description><![CDATA[Leading integrated radiotherapy systems maker Varian Medical Systems (VAR) recently disclosed that it has won Shonin approval from the Ministry of Health, Labor and Welfare (“MHLW”) in Japan to sell its TrueBeam system for image-guided radiotherapy as well as radiosurgery. TrueBeam is Varian’s most sophisticated cancer treatment system. It is especially suitable for therapy of lung and liver cancer, which are among the five most common cancers in Japan. Varian has designed its TrueBeam system to handle tumors with precision and speed. This includes tumors that tend to move, during therapy, as the patient breathes. This cutting edge technology integrates a series of technical improvements, which provide help during treatment, such as positioning the patient and managing his/her motion. The know-how has applications in all modes of sophisticated external-beam radiotherapy ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/20/var-varian-medical-systems-wins-shonin-in-japan/76601/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ADSK) Autodesk Enhances Partner Program</title>
		<link>http://www.stockbloghub.com/2011/04/19/adsk-autodesk-enhances-partner-program/71891</link>
		<comments>http://www.stockbloghub.com/2011/04/19/adsk-autodesk-enhances-partner-program/71891#comments</comments>
		<pubDate>Tue, 19 Apr 2011 19:28:19 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Technical & System Software]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[ADBE]]></category>
		<category><![CDATA[Adobe Systems Inc.]]></category>
		<category><![CDATA[ADSK]]></category>
		<category><![CDATA[ALC]]></category>
		<category><![CDATA[Assisted Living Concepts Inc.]]></category>
		<category><![CDATA[Autodesk Inc.]]></category>
		<category><![CDATA[AVID]]></category>
		<category><![CDATA[Avid Technology Inc]]></category>
		<category><![CDATA[Parametric Technology Corporation]]></category>
		<category><![CDATA[PMTC]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71891</guid>
		<description><![CDATA[Autodesk Inc. (ADSK) enhanced several components of its 2011 Autodesk Partner Program in a bid to boost its sales by increasing the capabilities of its global resellers. Autodesk’s global Partner Program was unveiled last year, with the intention of enhancing partner skills and thereby improving customer experience. The program enables resellers to provide better services, products and solutions to customers. The recently announced enhancements include Platinum Tier, where customers are provided with top level industry expertise and satisfactory customer service. The Partner Program also provides a list of new prospects that could help Autodesk’s value-added resellers (VAR) to expand their businesses. Autodesk Partner Program focuses on customer satisfaction and value. The core motive of the program is to help Autodesk customers find a complete set of solutions from their choice ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/19/adsk-autodesk-enhances-partner-program/71891/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ARAY) Accuray Analyst Lifts Shares to Outperform</title>
		<link>http://www.stockbloghub.com/2011/04/03/aray-accuray-analyst-lifts-shares-to-outperform/70472</link>
		<comments>http://www.stockbloghub.com/2011/04/03/aray-accuray-analyst-lifts-shares-to-outperform/70472#comments</comments>
		<pubDate>Mon, 04 Apr 2011 03:32:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Accuray Incorporated]]></category>
		<category><![CDATA[ARAY]]></category>
		<category><![CDATA[TOMO]]></category>
		<category><![CDATA[TomoTherapy Incorporated]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=70472</guid>
		<description><![CDATA[We upgrade our recommendation on Accuray Incorporated (ARAY) to Outperform following our assessment of its healthy second-quarter fiscal 2011 results and increased visibility on the stock. We are upbeat about the compelling prospect in radiation oncology rendered by the company’s impending acquisition of rival TomoTherapy (TOMO). Second quarter earnings per share of 7 cents comfortably beat the Zacks Consensus Estimate of a loss of 2 cents. The company swung to profit in the quarter as a decline in operating expenses offset lower revenues. Revenues declined 5% year over year to $54.2 million, but beat the Zacks Consensus Estimate of $49 million. The California-based company has once again backed its revenue outlook for fiscal 2011. Accuray is a global leader in the field of radiosurgery and provides a non-surgical treatment option ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/03/aray-accuray-analyst-lifts-shares-to-outperform/70472/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Industry Outlook &#8211; April 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413</link>
		<comments>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413#comments</comments>
		<pubDate>Thu, 31 Mar 2011 23:07:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Accuray Incorporated]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[ARAY]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[TOMO]]></category>
		<category><![CDATA[TomoTherapy Incorporated]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=70413</guid>
		<description><![CDATA[Last year was challenging for medical device companies given the exigent economic conditions and an uncertain healthcare environment. The MedTech industry was hit by several macro headwinds in 2010 including price/volume and utilization pressure and a more restrictive regulatory environment. Although a number of these issues remain, the industry is expected to fare better this year due to several tailwinds and growth opportunities. Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative, with estimated worldwide sales of more than $300 billion in 2011. The U.S. is the largest medical devices market, with estimated sales of roughly $95 billion in 2010. The medical devices industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (“HCIT”). The U.S. medical ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ARAY) Accuray&#8217;s CyberKnife Reaches 100,000 Patients Treated</title>
		<link>http://www.stockbloghub.com/2010/10/11/aray-accurays-cyberknife-reaches-100000-patients-treated/54594</link>
		<comments>http://www.stockbloghub.com/2010/10/11/aray-accurays-cyberknife-reaches-100000-patients-treated/54594#comments</comments>
		<pubDate>Mon, 11 Oct 2010 15:23:15 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Accuray Incorporated]]></category>
		<category><![CDATA[ARAY]]></category>
		<category><![CDATA[SI]]></category>
		<category><![CDATA[Siemens AG]]></category>
		<category><![CDATA[TOMO]]></category>
		<category><![CDATA[TomoTherapy Incorporated]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=54594</guid>
		<description><![CDATA[Leading radiosurgery systems maker Accuray Incorporated (ARAY) has achieved an important milestone as patients treated with its CyberKnife robotic radiosurgery system have reportedly reached the 100,000 mark. CyberKnife is a non-invasive alternative to traditional surgery and is the only commercially available intelligent robotic radiosurgery system designed to treat solid tumors anywhere in the body. Patients can be treated with CyberKnife without anesthesia and without the risks and complications inherent in traditional surgery. The CyberKnife system combines continuous image-guidance technology with a compact linear accelerator that has the ability to move in three dimensions according to the treatment plan. The CyberKnife procedure is well tolerated. Patients do not require substantial pre-treatment preparation, and typically there is little to no recovery time or hospital stay necessary for the CyberKnife procedure. All these ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/11/aray-accurays-cyberknife-reaches-100000-patients-treated/54594/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ARAY) Accuray Beats Earnings Estimate by 60%</title>
		<link>http://www.stockbloghub.com/2010/09/14/aray-accuray-beats-earnings-estimate-by-60/50103</link>
		<comments>http://www.stockbloghub.com/2010/09/14/aray-accuray-beats-earnings-estimate-by-60/50103#comments</comments>
		<pubDate>Tue, 14 Sep 2010 20:32:16 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Accuray Incorporated]]></category>
		<category><![CDATA[ARAY]]></category>
		<category><![CDATA[SI]]></category>
		<category><![CDATA[Siemens AG]]></category>
		<category><![CDATA[TOMO]]></category>
		<category><![CDATA[TomoTherapy Incorporated]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=50103</guid>
		<description><![CDATA[Accuray Inc. (ARAY), a global leader in the field of radiosurgery, reported fourth-quarter fiscal 2010 (ended June 30) earnings per share of 8 cents, exceeding the Zacks Consensus Estimate of 5 cent and the year-ago earnings of 2 cents. Net income for the quarter quadrupled year-over-year to $5 million on the back of higher product sales and the company&#8217;s cost-cutting initiatives. For fiscal 2010, net income surged to $2.8 million from $0.6 million a year-ago with earnings per share of 5 cents topping the Zacks Consensus Estimate of 1 cent. However, the California-based cancer surgery system maker released a tepid outlook for fiscal 2011, sending its shares down more than 3.5% to $6.32 in early morning trade, as the market appears to be discounting the better-than-expected results and focusing instead ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/09/14/aray-accuray-beats-earnings-estimate-by-60/50103/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(VAR) Varian Medical Systems Beats Expectations &#8211; Raises Guidance</title>
		<link>http://www.stockbloghub.com/2010/01/28/var-varian-medical-systems-beats-expectations-raises-guidance/26299</link>
		<comments>http://www.stockbloghub.com/2010/01/28/var-varian-medical-systems-beats-expectations-raises-guidance/26299#comments</comments>
		<pubDate>Thu, 28 Jan 2010 21:20:15 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=26299</guid>
		<description><![CDATA[Varian Medical Systems (VAR) has reported strong first quarter fiscal 2010 results. The company reported revenues of $540.94 million, up 6.3% from the corresponding period last year. Varian’s first quarter earnings per share (EPS) came in at 63 cents, which surpassed the Zacks Consensus Estimate and the year-ago quarter’s EPS by 7 cents. Earnings estimates were trending up recently, with two of the 10 analysts covering the stock raising their quarterly estimates in the last 30 days. In terms of earnings surprises, Varian has consistently reported above expectations. Varian had a positive surprise of 4% and 8% in the fourth and third quarters of fiscal 2009, respectively, with the four-quarter average of positive 7%. This means that, on an average, Varian has come ahead of the Zacks Consensus by 7% ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/28/var-varian-medical-systems-beats-expectations-raises-guidance/26299/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(VAR) Varian Medical Systems Analysts Initiated as Neutral</title>
		<link>http://www.stockbloghub.com/2010/01/12/var-varian-medical-systems-analysts-initiated-as-neutral/24741</link>
		<comments>http://www.stockbloghub.com/2010/01/12/var-varian-medical-systems-analysts-initiated-as-neutral/24741#comments</comments>
		<pubDate>Tue, 12 Jan 2010 23:26:02 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24741</guid>
		<description><![CDATA[We recently initiated coverage on Varian Medical Systems, Inc. (VAR) with a Neutral recommendation. We rate the stock as Neutral with a target price of $50 based on a P/E of roughly 18.6x our fiscal 2010 EPS estimate. Varian reported fourth-quarter earnings per share of 78 cents, surpassing the Zacks Consensus Estimate of 75 cents and the year-ago earnings of 68 cents. Total revenues in the fourth quarter increased 8% year over year to $642 million, with growth witnessed across all the major business segments. Net orders increased 4% year over year to $755 million. In full fiscal 2009, Varian reported earnings per share of $2.65, ahead of the Zacks Consensus Estimate of $2.62 and the year-ago earnings of $2.31. Total revenues increased 7% year over year to $2,214.1 million. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/12/var-varian-medical-systems-analysts-initiated-as-neutral/24741/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(VAR) Varian Medical Systems Bags New Customer</title>
		<link>http://www.stockbloghub.com/2009/12/27/var-varian-medical-systems-bags-new-customer/23533</link>
		<comments>http://www.stockbloghub.com/2009/12/27/var-varian-medical-systems-bags-new-customer/23533#comments</comments>
		<pubDate>Sun, 27 Dec 2009 23:46:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=23533</guid>
		<description><![CDATA[Varian Medical Systems, Inc. (VAR) recently reported having bagged a new customer for its RapidArc radiotherapy technology. The new customer is Hope International Centro de Radioterapia of Guatemala, an important cancer treatment facility in Latin America. Doctors at Hope International are presently treating four patients &#8211; one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme- an aggressive type of brain tumor, using Varian’s RapidArc radiotherapy technology. These are the first set of patients in Latin America to receive treatment using Varian RapidArc radiotherapy technology. The RapidArc radiotherapy technology from Varian uses a fast form of image-guided radiotherapy that enables clinicians to detect a 2-3 mm displacement of the targeted tumor after having positioned the patient for his first ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/27/var-varian-medical-systems-bags-new-customer/23533/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CRM) Salesforce Enters Strategic Partnership With Adobe</title>
		<link>http://www.stockbloghub.com/2009/11/07/crm-salesforce-enters-strategic-partnership-with-adobe/19804</link>
		<comments>http://www.stockbloghub.com/2009/11/07/crm-salesforce-enters-strategic-partnership-with-adobe/19804#comments</comments>
		<pubDate>Sun, 08 Nov 2009 00:39:01 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Internet Software & Services]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[ADBE]]></category>
		<category><![CDATA[Adobe Systems Inc.]]></category>
		<category><![CDATA[CRM]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[IBM]]></category>
		<category><![CDATA[International Business Machines]]></category>
		<category><![CDATA[Microsoft Corporation]]></category>
		<category><![CDATA[MSFT]]></category>
		<category><![CDATA[Salesforce.com]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=19804</guid>
		<description><![CDATA[Salesforce.com (CRM) has entered into a strategic business deal with Adobe Systems Incorporated (ADBE), whereby the entities will combine the cloud computing power of the Force.com with the Adobe Flash Platform in order to offer the customer a high quality Internet experience in the cloud. The combined service is presented as Adobe Flash Builder for Force.com, which will improve the end consumer Internet experience, as well as improve the productivity of web developers. This is another example of Salesforce.com’s diversification of its service offerings, utilizing the cloud computing platform. This time it is targeted at web developers, a rapidly growing market the world over. Adobe Flash Builder for Force.com is a powerful tool, which helps to produce cloud-based rich Internet applications (RIA), which can be easily used by the end ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/07/crm-salesforce-enters-strategic-partnership-with-adobe/19804/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CRM) Salesforce Opens Up Force.com</title>
		<link>http://www.stockbloghub.com/2009/08/28/crm-salesforce-opens-up-force-com/13813</link>
		<comments>http://www.stockbloghub.com/2009/08/28/crm-salesforce-opens-up-force-com/13813#comments</comments>
		<pubDate>Fri, 28 Aug 2009 23:14:53 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Internet Software & Services]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[CRM]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[IBM]]></category>
		<category><![CDATA[International Business Machine]]></category>
		<category><![CDATA[Microsoft Corporation]]></category>
		<category><![CDATA[MSFT]]></category>
		<category><![CDATA[Salesforce.com]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=13813</guid>
		<description><![CDATA[In an effort to expand the reach of Force.com, Salesforce.com (CRM) recently announced the new Force.com value-added reseller (VAR) program. As per this new program, the value-added resellers of Force.com will help their clients to develop and run applications on Force.com. Force.com basically enables companies to develop and run applications for public and private use, by taking help from Salesforce’s cloud computing platform. We believe this is an additional sales channel that the company has created for their Force.com sites. VARs are reputed software consultants, who will act as channel partners and resell the application developed in Force.com to other companies. We believe that the technical knowledge and customer winning ability of the VARs will add value and generate additional business for Salesforce. This apart, the most important factor in ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/08/28/crm-salesforce-opens-up-force-com/13813/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(VAR) Varian Medical Systems &#8211; average earnings surprise has exceeded estimates by 12%</title>
		<link>http://www.stockbloghub.com/2008/11/06/varian-medical-systems-average-earnings-surprise-has-exceeded-estimates-by-12/1273</link>
		<comments>http://www.stockbloghub.com/2008/11/06/varian-medical-systems-average-earnings-surprise-has-exceeded-estimates-by-12/1273#comments</comments>
		<pubDate>Thu, 06 Nov 2008 16:47:34 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[VitalStocks]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=1273</guid>
		<description><![CDATA[Varian Medical Systems, Inc. (VAR) just reported another earnings surprise along with increased revenue. The company also released its newest technology for cancer treatment. Company Description Varian Medical Systems, Inc. is the world&#8217;s leading supplier of equipment and software for treating cancer. The company is also a premier supplier of components including X-ray tubes and flat-panel detectors for medical, scientific, and industrial imaging. Varian employs approximately 3,900 who are located at manufacturing sites in North America and Europe and in its 55 sales and support offices around the world. Another Earnings Surprise On Oct 23 Varian announced fourth-quarter results including a 10% year-over-year increase in earnings per share, 68 cents up from 62 cents. Wall Street was expecting 62 cents, making this the fourth earnings surprise in as many quarters. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/11/06/varian-medical-systems-average-earnings-surprise-has-exceeded-estimates-by-12/1273/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

